Bioceltech Therapeutics, Ltd.
PrivateLast Round
Series A
Jun 2, 2023
Total Funding Raised
$8M
Company Overview
Bioceltech Therapeutics, Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A round in June 2023.
Bioceltech Therapeutics, Ltd. is a biotechnology company that focuses on the development and application of immunotherapy, including CAR-T cell therapies for the treatment of hematologic neoplasms and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioceltech Therapeutics, Ltd. Comparables
Compare Bioceltech Therapeutics, Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sichuan Neo-Immunotech Co., Ltd. | 79% | |
| Juventas Cell Therapy Ltd. | 79% | |
| AbelZeta Pharma | 78% |
For institutional investors. Book with your work email.
Bioceltech Therapeutics, Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2023 | ||||
| Angel | Jan 4, 2018 |
For institutional investors. Book with your work email.
Bioceltech Therapeutics, Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canica | Series A |
| Sandwater | Series A |
| Anlong Fund | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2023
Raised $8M with participation from Canica and Sandwater.
- Jan 4, 2018
Anlong Fund participated in the Angel round.
For institutional investors. Book with your work email.
Bioceltech Therapeutics, Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioceltech Therapeutics, Ltd.'s valuation, stock price, and market status.
Is Bioceltech Therapeutics, Ltd. a public or private company?
Bioceltech Therapeutics, Ltd. is a private company.
What is the current stock price of Bioceltech Therapeutics, Ltd.?
Bioceltech Therapeutics, Ltd. is a private company, so its shares have no public market price. Caplight tracks Bioceltech Therapeutics, Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioceltech Therapeutics, Ltd. worth (valuation)?
Valuation information for Bioceltech Therapeutics, Ltd. is not publicly available.
Can I buy Bioceltech Therapeutics, Ltd. stock?
Bioceltech Therapeutics, Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioceltech Therapeutics, Ltd.'s last funding round?
Bioceltech Therapeutics, Ltd.'s most recent funding round was Series A on June 2, 2023.
Who are the main investors in Bioceltech Therapeutics, Ltd.?
Key investors in Bioceltech Therapeutics, Ltd. include Canica, Sandwater, Anlong Fund.
Will Bioceltech Therapeutics, Ltd. IPO soon?
No public IPO plans have been announced for Bioceltech Therapeutics, Ltd..
How can I track Bioceltech Therapeutics, Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Bioceltech Therapeutics, Ltd.'s shares on secondary markets.